Clinical Trial Update: Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating the effects of Seroquel XR on sleep architecture in Major Depressive Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Ewha Womans University | Conditions: Major Depressive Disorder | Phase 2 | Status: WITHDRAWN